A study involving nearly 700,000 individuals diagnosed with type 2 diabetes or obesity revealed that participants treated with Ozempic or Wegovy had approximately a 50% reduced likelihood of experiencing cannabis use disorder compared to those on alternative medications. While Ozempic is commonly prescribed for type 2 diabetes management, it appears it may also decrease the risk associated with cannabis use disorder…
Learn More
